PBH - PBH プレステ―ジ・コンシュ―マ―・ヘルスケア （）

Prestige Consumer Healthcare Inc. (NYSE:NYSE:PBH) Q3 2023 Results Conference Call February 2, 2023 8:30 AM ETCompany ParticipantsPhil Terpolilli - Vice President of Investor Relations &…

Global Pregnancy Testing Devices Market Report 2023 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2030 (Based on 2023 COVID-19 Worldwide Spread) is the latest research study released by CMI evaluating the market risk side analysis, highlighting opportunities,

A share of Prestige Consumer Healthcare Inc. (NYSE:PBH) closed at $62.02 per share on Friday, up from $61.94 day before. While Prestige Consumer Healthcare Inc. has overperformed by 0.13%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PBH rose by 0.23%, with highs and lows ranging […]

Prestige Consumer Healthcare Inc. (NYSE:PBH) concluded the trading at $60.61 on Friday, December 16 with a rise of 0.25% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $60.46 and 5Y monthly beta was reading 0.59 with its price kept floating in … New Insight On Prestige Consumer Healthcare Inc. (PBH) Read More »

Related Stocks: PBH ,

TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on Thursday, May 5, 2022 after the market close. The following morning, May 6, at 8:30 a.m. ET, the Company will host a conference call to discuss the results as well as for a discussion into the Company’s leading business attributes.

TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021.

Prestige Consumer Healthcare Inc (PBH) shares closed today at 1.1% below its 52 week high of $63.83, giving the company a market cap of $3B. The stock is currently up 79.2% year-to-date, up 77.6% over the past 12 months, and up 20.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 57.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 434.2% The company's stock price performance over the past 12 months beats the peer average by 402.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

TARRYTOWN, N.Y., Oct. 06, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 second quarter earnings release on Thursday, November 4, 2021 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. … The post Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results appeared first on ForexTV .

The Head Lice Infestation Treatment market Research Report is an In-depth analysis of overall market size, share, trends and growth prospects in the market. The Head Lice Infestation Treatment market is a comprehensive analysis of Competitive Landscape and Manufacturing Factor

Major players in the electrolyte mixes market are PepsiCo Inc. , The Coca-Cola Company, LyteLine LLC, Nestle Health Science S. A. , Vega, Ultima Health Products Inc. , Abbott Laboratories, Tailwind Nutrition, Cargill, Prestige Brands Holdings Inc. Major players in the electrolyte mixes market are PepsiCo Inc. , The Coca-Cola Company, LyteLine LLC, Nestle Health Science S. A. , Vega, Ultima Health Products Inc. , Abbott Laboratories, Tailwind Nutrition, Cargill, Prestige Brands Holdings Inc.

Prestige Consumer Healthcare Inc (PBH) shares closed 0.3% higher than its previous 52 week high, giving the company a market cap of $2B. The stock is currently up 67.5% year-to-date, up 46.2% over the past 12 months, and up 17.7% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 1.0%. Trading Activity Trading volume this week was 94.3% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 890.3% The company's stock price performance over the past 12 months beats the peer average by 325.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 8.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.